Celladon
ID: 5290471Celladon is a biotechnology company that focuses in the development of molecular therapies to treat heart failure.
10
Funding Rounds
$152.2m
Money raised
Recent Funding Rounds
Overview
Celladon is a biotechnology company that focuses in the development of molecular therapies to treat heart failure.
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro*** Ha**** |
|
- |
Funding series
Funding Series Analysis
The company Celladon has raised a total of $30m in funding over 10 rounds.
Key Insights:
- Celladon Series B round: $30m
- Celladon funding round, February 2012: $43m
- Celladon Venture round, November 2015: $39.5m
- Celladon Venture round, October 2013: $1.1m
- Celladon Venture round, May 2012: $10m
- Celladon Venture round, December 2011: $500k
- Celladon Venture round, September 2011: $250k
- Celladon Venture round, October 2010: $2.5m
- Celladon Venture round, December 2009: $3.5m
- Celladon Series C round, November 2009: $21.8m
Industries
Celladon is active in the following industries: